(Q43627799)
Statements
1 reference
Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy (English)
1 reference
1 reference
Jounaidi Y
1 reference
1 June 2001
1 reference
1 reference
61
1 reference
11
1 reference
4437-4444
1 reference
Identifiers
1 reference